Document is current
Any future updates will be listed below
-
Authors
Tynkkynen, Niko P. https://orcid.org/0000-0001-8245-1275
Joensuu, Laura https://orcid.org/0000-0002-9544-6552
Herranen, Päivi https://orcid.org/0000-0002-4539-327X
Kaprio, Jaakko https://orcid.org/0000-0002-3716-2455
Törmäkangas, Timo https://orcid.org/0000-0001-7268-5297
Sillanpää, Elina https://orcid.org/0000-0001-6375-959X
- License Information
-
More Information
Article History
Received: 11 February 2026
Revised: 7 July 2026
Accepted: 10 July 2026
First Online: 25 July 2026
Declarations
Ethical approval: The older FTC Study received ethical approval from the Ethics Committees of the University of Helsinki and Helsinki University Central Hospital. All participants provided written informed consent. Data collection was conducted in accordance with the principles of the Declaration of Helsinki. The UK Biobank study was approved by the North West Multi-Centre Research Ethics Committee (approval no. 11/NW/0382). LifeGen consortium cohort studies were approved by their respective local committees, with written informed consent obtained from each participant.
Competing interests: The authors declare no competing interests.
